Dr. Peter Bambakidis, MD

Dr. Bambakidis practices at Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Bambakidis' NPI, 1598731275, was assigned on February 23, 2006. Dr. Bambakidis graduated from Cleveland Medical College, Homeopathic in 1984. Dr. Bambakidis holds Ohio license 35058627B.

Dr. Bambakidis' primary practice is Fairview Hospital, at 18101 Lorain Avenue, Cleveland, OH 44111 in Cuyahoga County. The practice phone is (216) 476-7000.

Dr. Bambakidis' primary practice is Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Bambakidis is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Bambakidis to 3 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bambakidis practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bambakidis' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bambakidis is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bambakidis' licenses on file in 2 states: Ohio and Minnesota.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, encephalopathy, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Bambakidis treats.

CMS data shows 584 Medicare services from Dr. Bambakidis across 6 procedure codes in 2024, for 285 Medicare patients. Medicare paid $24,879 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 285 Medicare patients who saw Dr. Bambakidis in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bambakidis' median patient age at 64, with 60% women.

In 2024, Dr. Bambakidis wrote 2,476 Medicare Part D claims for 368 patients. 94% of them were for generic drugs. CMS names the drug for 2,297 of them, across 38 drugs with 11 or more claims each, at $107,391 in total drug cost. In 2023, CMS named 2,069 claims across 35 drugs.

Dr. Bambakidis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bambakidis as offering telehealth.

Dmand AI links 2 papers to Dr. Bambakidis, published from 2022 to 2023. Dr. Bambakidis has published most often in J Neurosurg. Dr. Bambakidis' most frequent co-authors are Mohamad Bydon, MD, Panagiotis Kerezoudis, MD, MS and Nikita Lakomkin, MD.

CMS Open Payments shows 10 general payments to Dr. Bambakidis from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 96% of the total. Boston Scientific Corporation paid the most, $140.

Dmand AI lists 2 awards for Dr. Bambakidis, most recently CMS Stage 1 EHR in 2012.

Dr. Bambakidis graduated from Cleveland Medical College, Homeopathic in 1984. Dr. Bambakidis is a member of AAN.

Dr. Bambakidis is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.